"They have the hearts and minds of today's most affluent consumers." He added, like luxury companies, Apple's marketing is "image driven and highly creative." The company also has "impeccable products, service and merchandising," like the best luxe …

China's appetite for milk and dairy products has been rapidly accelerating in recent years, as its consumers become increasingly affluent and adopt a more westernised diet. However, slowed growth in milk production has already seen the country's …

Josh Meyer, 30, a products manager at a leading high-tech firm, recognizes the generation gap. He said higher-level managers who have been in the industry for decades often wear baggy khakis and faded … With the nation's highest concentration of high …

The company continues to focus on its core food and beverage offerings but it has also developed some new products that appeal to local tastes, and its stores are to support a dine-in experience. Respecting the tea culture of China, Starbucks launched …

The government has also rightly decided that well to do and affluent domestic consumers would not benefit from tariff charged to lower slabs as was the case in the past since they can and should pay the cost of using electricity. The Tariff Structure …

AD provides exclusive access to the world's most beautiful homes and the fascinating people who live in them, bringing its audience a wealth of information on architecture and interior design, art and antiques, travel destinations, and extraordinary …

The group, formed earlier this year, includes Capstone Investment Banking, Capstone Merchant Banking and Capstone Affluent Strategies, with $1.5 billion of assets under administration. Pastor sees the group growing from a combined 45 people now to …

To some extent the existence of this kind of restaurant may crowd out dining at other eateries in Cleveland, but mostly it serves to generate a whole new class of products — authentic Chinese cooking — that otherwise wouldn't exist in the area …

This is simply explained by profit motives. Hollis and Pogge, two professors, have estimated that about six billion dollars a year would be needed to sufficiently fund drug company incentives to register products that target diseases that commonly …